Literature DB >> 17012664

Brain volume changes in the first year of illness and 5-year outcome of schizophrenia.

W Cahn1, N E M van Haren, H E Hulshoff Pol, H G Schnack, E Caspers, D A J Laponder, R S Kahn.   

Abstract

Progressive brain volume changes have been reported in first-episode schizophrenia, but their relationship to the disease process or to other factors remains unclear. We examined such changes in the first year of illness, and related them to 5-year outcome. Progressive brain volume changes, in particular of grey matter, during the first year of illness were found to be significantly associated with clinical and functional outcome 5 years after the first episode. These findings suggest that early dynamic brain volume changes are related to the disease process and predict the longer-term outcome of schizophrenia.

Entities:  

Mesh:

Year:  2006        PMID: 17012664     DOI: 10.1192/bjp.bp.105.015701

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  42 in total

Review 1.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

Review 2.  Antipsychotic drugs for first-episode schizophrenia: a comparative review.

Authors:  Kayvon Salimi; L Fredrik Jarskog; Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

3.  Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia?

Authors:  Adrienne C Lahti; Meredith A Reid
Journal:  Neuropsychopharmacology       Date:  2011-08       Impact factor: 7.853

4.  The Course and Correlates of Everyday Functioning in Schizophrenia.

Authors:  Abraham Reichenberg; Concetta Feo; Davide Prestia; Christopher R Bowie; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2014-03-01

5.  Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Authors:  Mohamed Ahmed; Dara M Cannon; Cathy Scanlon; Laurena Holleran; Heike Schmidt; John McFarland; Camilla Langan; Peter McCarthy; Gareth J Barker; Brian Hallahan; Colm McDonald
Journal:  Neuropsychopharmacology       Date:  2015-04-01       Impact factor: 7.853

6.  Association of Age at Onset and Longitudinal Course of Prefrontal Function in Youth With Schizophrenia.

Authors:  Tara A Niendam; Kimberly L Ray; Ana-Maria Iosif; Tyler A Lesh; Stefania R Ashby; Pooja K Patel; Jason Smucny; Emilio Ferrer; Marjorie Solomon; J Daniel Ragland; Cameron S Carter
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

Review 7.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

8.  Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia.

Authors:  Leonardo Bonilha; Chris Molnar; Michael D Horner; Berry Anderson; Lauren Forster; Mark S George; Ziad Nahas
Journal:  Schizophr Res       Date:  2007-12-31       Impact factor: 4.939

9.  [Not Available].

Authors:  Serge A Mitelman; Emily L Canfield; Randall E Newmark; Adam M Brickman; Yuliya Torosjan; King-Wai Chu; Erin A Hazlett; M Mehmet Haznedar; Lina Shihabuddin; Monte S Buchsbaum
Journal:  Open Neuroimag J       Date:  2009-05-20

10.  White matter microstructure in schizophrenia: effects of disorder, duration and medication.

Authors:  Richard Kanaan; Gareth Barker; Michael Brammer; Vincent Giampietro; Sukhwinder Shergill; James Woolley; Marco Picchioni; Timothea Toulopoulou; Philip McGuire
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.